v3.21.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Jun. 30, 2020
ASSETS    
Cash $ 1,041,899 $ 197,622
Accounts receivable (net of allowance of $0 and $0, respectively) 109,589 61,013
Inventories (net of allowance of $24,403 and $0, respectively) 387,736 275,605
Other current assets 33,480 398,085
Total current assets 1,572,704 932,325
Total assets 1,572,704 932,325
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Accounts payable 459,703 1,286,149
Accrued expense-related party 3,000 9,974
Accrued interest   192,625
Convertible notes payable-net of debt discounts and unamortized beneficial conversion feature   2,330,189
Fair value of derivative liabilities   1,590,638
Short-term borrowings- line of credit   3,897
Total current liabilities 462,703 5,413,472
Total liabilities 462,703 5,413,472
Commitments and contingencies  
Stockholders’ equity (deficit):    
Series A Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of June 30, 2021 and 2020, respectively) 1 1
Series B Stock, ($0.001 par value, 5,000 shares authorized, and 4,665 and 0 issued and outstanding as of June 30, 2021 and 2020, respectively) 5 0
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 80,707,467 issued and outstanding as of June 30, 2021 and 61,796,680 issued and outstanding as of June 30, 2020, respectively) 80,707 61,797
Additional paid in capital 26,226,159 13,088,177
Accumulated deficit (25,196,871) (17,631,122)
Total stockholders’ equity (deficit) 1,110,001 (4,481,147)
Total liabilities and stockholders’ equity (deficit) $ 1,572,704 $ 932,325

Source